CLINICAL_TRIALS
ClinicalTrials.gov record update
Galactose Supplementation for the Treatment of Patients With Mild Malformation of Cortical Development With Oligodendroglial Hyperplasia in Epilepsy (MOGHE): a Pilot Trial
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04833322
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:14.215326+00:00
- Published At
- 2021-04-06T00:00:00+00:00
- Record Updated At
- 2021-04-06
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Refractory Epilepsy", "SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-04-06"- protocolSection.identificationModule.nctId
"NCT04833322"- protocolSection.identificationModule.officialTitle
"Galactose Supplementation for the Treatment of Patients With Mild Malformation of Cortical Development With Oligodendroglial Hyperplasia in Epilepsy (MOGHE): a Pilot Trial"- protocolSection.statusModule.overallStatus
"UNKNOWN"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.